Common Contracts
3 similar Securities Purchase Agreement contracts by Vermillion, Inc., Biolase, Inc
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 17th, 2017 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • Delaware
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) dated February 13, 2017, is entered into by and among (i) Vermillion, Inc., a Delaware corporation (the “Company”), and (ii) each investor listed on Schedule I (each, an “Investor” and, collectively, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 24th, 2014 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • Delaware
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) dated December 19, 2014, is entered into by and among (i) Vermillion, Inc., a Delaware corporation (the “Company”), and (ii) each person listed on Schedule I (each, an “Investor” and, collectively, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 7th, 2014 • Biolase, Inc • Dental equipment & supplies • Delaware
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) dated November 3, 2014, is entered into by and among (i) Biolase, Inc., a Delaware corporation (the “Company”), and (ii) each person listed on Schedule I (each, an “Investor” and, collectively, the “Investors”).
